1. Home
  2. CELZ vs IDAI Comparison

CELZ vs IDAI Comparison

Compare CELZ & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELZ
  • IDAI
  • Stock Information
  • Founded
  • CELZ 1998
  • IDAI 2016
  • Country
  • CELZ United States
  • IDAI United States
  • Employees
  • CELZ N/A
  • IDAI N/A
  • Industry
  • CELZ Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • CELZ Health Care
  • IDAI Technology
  • Exchange
  • CELZ Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • CELZ 7.4M
  • IDAI 7.7M
  • IPO Year
  • CELZ N/A
  • IDAI N/A
  • Fundamental
  • Price
  • CELZ $3.39
  • IDAI $3.08
  • Analyst Decision
  • CELZ
  • IDAI Strong Buy
  • Analyst Count
  • CELZ 0
  • IDAI 1
  • Target Price
  • CELZ N/A
  • IDAI $12.00
  • AVG Volume (30 Days)
  • CELZ 32.0K
  • IDAI 1.6M
  • Earning Date
  • CELZ 11-07-2025
  • IDAI 11-14-2025
  • Dividend Yield
  • CELZ N/A
  • IDAI N/A
  • EPS Growth
  • CELZ N/A
  • IDAI N/A
  • EPS
  • CELZ N/A
  • IDAI N/A
  • Revenue
  • CELZ $6,000.00
  • IDAI $3,366,415.00
  • Revenue This Year
  • CELZ N/A
  • IDAI $25.13
  • Revenue Next Year
  • CELZ N/A
  • IDAI $48.09
  • P/E Ratio
  • CELZ N/A
  • IDAI N/A
  • Revenue Growth
  • CELZ N/A
  • IDAI N/A
  • 52 Week Low
  • CELZ $1.69
  • IDAI $1.43
  • 52 Week High
  • CELZ $6.90
  • IDAI $18.75
  • Technical
  • Relative Strength Index (RSI)
  • CELZ 51.48
  • IDAI 49.90
  • Support Level
  • CELZ $3.11
  • IDAI $3.16
  • Resistance Level
  • CELZ $3.37
  • IDAI $3.36
  • Average True Range (ATR)
  • CELZ 0.17
  • IDAI 0.47
  • MACD
  • CELZ -0.02
  • IDAI -0.02
  • Stochastic Oscillator
  • CELZ 41.84
  • IDAI 17.81

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

Share on Social Networks: